Paul Tudor Jones’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Sell
62,026
-68,058
-52% -$1.58M ﹤0.01% 2100
2026
Q1
$2.68M Buy
+130,084
New +$2.93M 0.01% 1639
2025
Q4
Sell
-22,986
Closed -$572K 3946
2025
Q3
$572K Sell
22,986
-445,865
-95% -$9.6M ﹤0.01% 2619
2025
Q2
$10.8M Buy
468,851
+313,241
+201% +$7.25M 0.02% 621
2025
Q1
$3.49M Sell
155,610
-112,289
-42% -$2.61M 0.01% 986
2024
Q4
$5.24M Buy
267,899
+37,904
+16% +$751K 0.02% 664
2024
Q3
$4.19M Buy
+229,995
New +$4.39M 0.02% 795

Other funds holding PRVA

Paul Tudor Jones's PRVA Position: Q2 2026 in Review

Paul Tudor Jones reduced its Privia Health (PRVA) stake by 52% in Q2 2026, selling an estimated $1.58M and leaving 62,026 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2100.

Paul Tudor Jones first reported a position in PRVA in Q3 2024 and has held it in 7 quarters since. The position peaked at $10.8M in Q2 2025. 300 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Paul Tudor Jones held 62,026 shares of Privia Health worth $1.6M as of Q2 2026.
  • Paul Tudor Jones sold 68,058 Privia Health shares in Q2 2026, an estimated $1.58M.
  • Privia Health made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2100 holding.
  • Paul Tudor Jones first reported a position in Privia Health in Q3 2024 and has held it in 7 quarters since.
  • Paul Tudor Jones's Privia Health position peaked at $10.8M in Q2 2025.
  • 300 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.